Ophelia blog · May 2025
Ophelia and Brave Health announced a partnership to connect opioid use disorder treatment with mental health services, including coordinated referrals and broader support for Medicaid-focused populations.
Medication & support to beat opioid addiction from home
Public company, workplace, funding, and market signals
Ophelia is a privacy-focused telehealth company that provides evidence-based treatment for opioid use disorder at home, combining medication-assisted treatment, video visits, care coordination, and ongoing support.
Primary product
Virtual medication-assisted treatment (MAT) for opioid use disorder using Suboxone/buprenorphine-naloxone plus clinician and care-team support.
Founded
2020
Headquarters
New York, New York, United States
Team size
51-200
Work style
Remote
Industry
Mental Health Care
Sub-industry
Telehealth treatment for opioid use disorder
Offices
Business model
Stage
Series B
Total raised
$67.8M
Latest round
Series B · Dec 2021
Latest amount
$50M
Leadership
Co-Founder & CEO
Chief Medical Officer
Chief Operating Officer
Chief Financial Officer
Chief Marketing Officer
Chief Technology Officer
Chief Commercial Officer
Remote-first, mission-driven, privacy-conscious, and clinically rigorous; the company emphasizes nonjudgmental support, evidence-based care, cross-functional collaboration, and flexible clinician schedules.
Work style
Remote
Visa sponsorship
No
Compensation
Public job postings show broad salary bands of about $120k-$130k for entry software engineering, $140k-$150k for mid-level engineering, and $185k-$195k for engineering management, plus strong benefits and remote work.
Benefits
Pricing
Subscription-based telehealth care with insurance reimbursement and cash-pay options.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Estimated monthly visits
824.4K
Traffic estimate as of Jun 2026
Ophelia blog · May 2025
Ophelia and Brave Health announced a partnership to connect opioid use disorder treatment with mental health services, including coordinated referrals and broader support for Medicaid-focused populations.
Ophelia blog · Apr 2025
Ophelia announced a strategic partnership with Spring Health to pair OUD treatment with therapy and psychiatric support for employers and health plans.
PR Newswire · Oct 2024
Ophelia expanded Medicaid coverage in New Jersey, broadening access to MOUD treatment statewide through new payer relationships.
PR Newswire · Jun 2024
Ophelia added Marc Russo and Trip Hofer to its board to support payer growth, network expansion, and Medicaid/commercial partnerships.